Crescent Acquisition - Unit (1 Ordinary share Cls A & 1/2 Wrt) EBIT

As of the most recent data (September 2023), CRSAU shows a EBIT of $-20M. That compares with $-42M in the prior-year period — up 53.2% year over year. That is above the sector sector average of $-77M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CRSAU's EBIT is now $-20M (was $-42M) — a 53.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Crescent Acquisition - Unit (1 Ordinary share Cls A & 1/2 Wrt) is outperforming or lagging.

The its sector sector average EBIT is about $-77M. Crescent Acquisition - Unit (1 Ordinary share Cls A & 1/2 Wrt) is at $-20M, which is higher that average. That is roughly 74.4% above the sector mean. Use the comparison chart on this page to see how CRSAU stacks up against individual peers as well.

Tracking CRSAU's ebit over time shows whether Crescent Acquisition - Unit (1 Ordinary share Cls A & 1/2 Wrt) is scaling, shrinking, or reshaping that part of the business. The current reading is $-20M That compares with $-42M in the prior-year period — up 53.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Crescent Acquisition - Unit (1 Ordinary share Cls A & 1/2 Wrt)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-20M) with ownership activity and broader fundamentals.